Among 21 analysts covering Monster Beverage Corp ( NASDAQ:MNST ), 16 have Buy rating, 1 Sell and 4 Hold.
Credit Suisse downgraded Monster Beverage Corporation (NASDAQ:MNST) on Wednesday, September 6 to “Hold” rating.
Susquehanna maintained Monster Beverage Corporation (NASDAQ:MNST) on Monday, August 7 with “Hold” rating.
Bioverativ Inc., a biotechnology company, focuses on the research, discovery, development, and commercialization of therapies for the treatment of hemophilia and other blood disorders in the United States and Japan.
After $0.63 actual earnings per share reported by Bioverativ Inc. for the previous quarter, Wall Street now forecasts -23.81% negative EPS growth.
READ MORE (UtahHerald.com)
- Looking From A Larger Picture Perspective: Omnicom Group Inc. (OMC), Monster ...Post Analyst
- Monster Beverage Corporation (MNST)'s Trend Up, Especially After Today's 52 ...BZ Weekly
- Check out the best stock list in todays market: Monster Beverage Corporation ...The News Journal
- Monster Beverage (NASDAQ:MNST) Earns “Outperform” Rating from Credit Suisse GroupDispatch Tribunal
- Monster Beverage Co. (MNST) Shares Sold by Livforsakringsbolaget Skandia ...StockNewsTimes
- What's Happening to These Stocks? Monster Beverage Corporation (MNST), Papa ...StandardOracle
- Central Bank & Trust Co. Raises Holdings in Monster Beverage Co. (NASDAQ:MNST)StockNewsTimes
- Monster Beverage Corporation (MNST) Position Lowered by Hartford Investment ...BangaloreWeekly
- Brokerages Anticipate Monster Beverage Co. (MNST) to Announce $0.37 Earnings ...The Ledger Gazette